Brain organoids can be induced from hiPSCs from patients with familial AD (APP, PSEN1, and PSEN2 mutations) or patients with sporadic AD, leading to the identification of modulators of the tau interactome, reproduction of AD pathology, and findings of cell fate changes in AD organoids [99–101]. Here, MAPT is linked to Alzheimer disease.